Updates
New analytical methods, application notes, impurity standards and other changes to our services, newest first.
November 2026
- Application noteTechnical article — SEC for aggregates and fragments: system suitability, ChP/USP/EP criteria and integration rules
- Application noteTechnical article — residual HCP and Protein A immunoassays: antibody coverage, bridging and the hook effect
- Impurity standardsImpurity library: five cagrilintide standards added (free acid, reduced form, disulfide dimers, [Asp21])
- Application noteTechnical article — amino acid analysis: hydrolysis recovery, molar-ratio reporting and net peptide content
- Application noteRegulatory: key points of the EMA synthetic peptide guideline (effective 1 June 2026)
- Application noteRegulatory: synthetic peptide requirements compared — China CDE, US FDA and EU EMA
- Application noteTechnical article — CD secondary structure: reference sets, concentration normalization and HT-voltage cut-offs
- New productNew product: CHO-GLP-1 luciferase reporter cell line (T82011) for GLP-1R potency testing
- Application noteTechnical article — icIEF charge heterogeneity: pI calibration, focusing completeness and peak-area limits
- New methodFour new method pages: SV-AUC, circular dichroism, icIEF and cell-based bioassay
- WebsiteThe website is now available in Spanish and Portuguese